How the HTLV-1 retrovirus leads to adult T‑cell leukemia
Retrovirus Models of Cancer
Researchers are using models of the HTLV‑1 virus to learn how it turns CD4+ T cells into adult T‑cell leukemia/lymphoma and to explore ways to prevent or treat this disease.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11198128 on NIH RePORTER |
What this research studies
From my perspective, the team uses lab-grown cells and animal models to reproduce HTLV‑1 infection and watch how infected CD4+ T cells change over time. They focus on viral factors like the hbz gene and host factors such as CTCF, and they study how infected cells send signals (including extracellular vesicles) that can harm bone and promote cancer. They are also testing prevention and treatment ideas, including an envelope mRNA vaccine and targeted anticancer approaches. Most work is done at Washington University and may involve patient samples or lead to future clinical testing.
Who could benefit from this research
Good fit: People with confirmed HTLV‑1 infection, patients diagnosed with adult T‑cell leukemia/lymphoma (ATLL), or individuals at high risk due to exposure in endemic areas would be the most relevant candidates.
Not a fit: People without HTLV‑1 infection or without T‑cell malignancies, and those with unrelated cancers or conditions, are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could lead to vaccines or targeted treatments that prevent HTLV‑1 infection or improve outcomes for people with ATLL.
How similar studies have performed: Related preclinical work from this group has shown promising findings (for example on hbz, CTCF, extracellular vesicles, and an envelope mRNA vaccine), but these approaches are not yet established standard treatments.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ratner, Lee — Washington University
- Study coordinator: Ratner, Lee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.